Drug and Therapeutics Bulletin 2007;45:2-4; doi:10.1136/dtb.2007.4512
Copyright © 2007 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Read responses to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Treating impetigo in primary care

Relevant BNF sections: 5.1, 13.10.1

Impetigo is a superficial, but contagious, bacterial infection of the skin that predominantly affects children and is common in primary care. In UK general practice, around half of the people with impetigo are treated with topical fusidic acid.1 However, bacterial resistance to this antibacterial drug is increasing.2 Here we discuss how patients with impetigo should be treated.




This article has been cited by other articles:


Home page
 DTBHome page
{blacktriangledown}Retapamulin for impetigo and other infections
DTB, October 1, 2008; 46(10): 76 - 79.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

This is a test
dom mitchell
dtb.bmj.com, 30 Jul 2007 [Full text]

About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 2007 BMJ Publishing Group Ltd.